{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T05:55:16Z","timestamp":1718171716522},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00103-019-02913-1","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T07:33:21Z","timestamp":1551339201000},"page":"450-461","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impfkomplikationen und der Umgang mit Verdachtsf\u00e4llen"],"prefix":"10.1007","volume":"62","author":[{"given":"Doris","family":"Oberle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Mentzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabia","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renz","family":"Streit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Wei\u00dfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Keller-Stanislawski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"issue":"5","key":"2913_CR1","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1056\/NEJMp1715349","volume":"378","author":"AW Boylston","year":"2018","unstructured":"Boylston AW (2018) The myth of the milkmaid. N\u00a0Engl J Med 378(5):414\u2013415. \n                    https:\/\/doi.org\/10.1056\/NEJMp1715349","journal-title":"N Engl J Med"},{"key":"2913_CR2","volume-title":"An inquiry into the causes and effects of variolae vaccinae, a\u00a0disease discovered in some western counties of England","author":"E Jenner","year":"1798","unstructured":"Jenner E (1798) An inquiry into the causes and effects of variolae vaccinae, a\u00a0disease discovered in some western counties of England. Sampson Low, London"},{"key":"2913_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fimmu.2011.00021","volume":"2","author":"KA Smith","year":"2011","unstructured":"Smith KA (2011) Edward Jenner and the small pox vaccine. Front Immunol 2:21. \n                    https:\/\/doi.org\/10.3389\/fimmu.2011.00021","journal-title":"Front Immunol"},{"key":"2913_CR4","first-page":"17","volume":"1","author":"D Mentzer","year":"2018","unstructured":"Mentzer D, Oberle D, Keller-Stanislawski B (2018) Daten zur Pharmakovigilanz von Impfstoffen aus dem Jahr 2016. Bull Arzneimittelsicherh 1:17\u201324","journal-title":"Bull Arzneimittelsicherh"},{"key":"2913_CR5","volume-title":"Causality assessment of an Causality assessment of anadverse event following immunization (AEFI). User manual for the revised WHO classification","author":"WHO","year":"2013","unstructured":"WHO (2013) Causality assessment of an adverse event following immunization (AEFI). User manual for the revised WHO classification. \n                    www.who.int\/vaccine_safety\/publications\/aevi_manual.pdf\n                    \n                  ; Zugegriffen: 26.02.2019"},{"issue":"5","key":"2913_CR6","first-page":"E52","volume":"102","author":"MM Braun","year":"1998","unstructured":"Braun MM, Terracciano G, Salive ME et al (1998) Report of a\u00a0US public health service workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization. Pediatr Electron Pages 102(5):E52","journal-title":"Pediatr Electron Pages"},{"issue":"49\u201350","key":"2913_CR7","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1016\/j.vaccine.2006.07.008","volume":"24","author":"PE Vermeer-de Bondt","year":"2006","unstructured":"Vermeer-de Bondt PE, Dzaferagi\u0107 A, David S, van der Maas NAT (2006) Performance of the Brighton collaboration case definition for hypotonic-hyporesponsive episode (HHE) on reported collapse reactions following infant vaccinations in the Netherlands. Vaccine 24(49\u201350):7066\u20137070. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2006.07.008","journal-title":"Vaccine"},{"issue":"4","key":"2913_CR8","doi-asserted-by":"publisher","first-page":"E52","DOI":"10.1542\/peds.106.4.e52","volume":"106","author":"TS DuVernoy","year":"2000","unstructured":"DuVernoy TS, Braun MM (2000) Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996\u20131998. Pediatrics 106(4):E52","journal-title":"Pediatrics"},{"issue":"6","key":"2913_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2017.1287642","volume":"13","author":"A Vigo","year":"2017","unstructured":"Vigo A, Costagliola G, Ferrero E, Noce S (2017) Hypotonic-hyporesponsive episodes after administration of hexavalent DTP-based combination vaccine. A description of 12 cases. Hum Vaccin Immunother 13(6):1\u20134. \n                    https:\/\/doi.org\/10.1080\/21645515.2017.1287642","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"2913_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1097\/INF.0000000000000715","volume":"34","author":"D Rosillon","year":"2015","unstructured":"Rosillon D, Buyse H, Friedland LR, Ng S\u2011P, Vel\u00e1zquez FR, Breuer T (2015) Risk of intussusception after rotavirus vaccination. Meta-analysis of postlicensure studies. Pediatr Infect Dis\u00a0J 34(7):763\u2013768. \n                    https:\/\/doi.org\/10.1097\/INF.0000000000000715","journal-title":"Pediatr Infect Dis J"},{"issue":"34","key":"2913_CR11","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1016\/j.vaccine.2009.05.056","volume":"27","author":"SJ Jacobsen","year":"2009","unstructured":"Jacobsen SJ, Ackerson BK, Sy LS et\u00a0al (2009) Observational safety study of febrile convulsion following first dose MMRV vaccination in a\u00a0managed care setting. Vaccine 27(34):4656\u20134661. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2009.05.056","journal-title":"Vaccine"},{"issue":"6","key":"2913_CR12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.vaccine.2013.12.011","volume":"32","author":"T Schink","year":"2014","unstructured":"Schink T, Holstiege J, Kowalzik F, Zepp F, Garbe E (2014) Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination. Vaccine 32(6):645\u2013650. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.011","journal-title":"Vaccine"},{"issue":"51","key":"2913_CR13","doi-asserted-by":"publisher","first-page":"8049","DOI":"10.1016\/j.vaccine.2010.10.005","volume":"28","author":"S Atanasoff","year":"2010","unstructured":"Atanasoff S, Ryan T, Lightfoot R, Johann-Liang R (2010) Shoulder injury related to vaccine administration (SIRVA). Vaccine 28(51):8049\u20138052. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2010.10.005","journal-title":"Vaccine"},{"issue":"4","key":"2913_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.vaccine.2006.08.034","volume":"25","author":"M Bodor","year":"2007","unstructured":"Bodor M, Montalvo E (2007) Vaccination-related shoulder dysfunction. Vaccine 25(4):585\u2013587. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2006.08.034","journal-title":"Vaccine"},{"issue":"3","key":"2913_CR15","doi-asserted-by":"publisher","first-page":"605","DOI":"10.4161\/hv.27232","volume":"10","author":"IF Cook","year":"2014","unstructured":"Cook IF (2014) Subdeltoid\/subacromial bursitis associated with influenza vaccination. Hum Vaccin Immunother 10(3):605\u2013606","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"2913_CR16","first-page":"303","volume":"45","author":"GB Cross","year":"2016","unstructured":"Cross GB, Moghaddas J, Buttery J, Ayoub S, Korman TM (2016) Don\u2019t aim too high. Avoiding shoulder injury related to vaccine administration. Aust Fam Physician 45(5):303\u2013306","journal-title":"Aust Fam Physician"},{"issue":"2","key":"2913_CR17","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.3928\/01477447-20120123-26","volume":"35","author":"PJ Messerschmitt","year":"2012","unstructured":"Messerschmitt PJ, Abdul-Karim FW, Iannotti JP, Gobezie RG (2012) Progressive osteolysis and surface chondrolysis of the proximal humerus following influenza vaccination. Orthopedics 35(2):e283\u2013e286. \n                    https:\/\/doi.org\/10.3928\/01477447-20120123-26","journal-title":"Orthopedics"},{"issue":"13","key":"2913_CR18","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1017\/S0950268818001802","volume":"146","author":"AL Halpin","year":"2018","unstructured":"Halpin AL, Gu W, Wise ME, Sejvar JJ, Hoekstra RM, Mahon BE (2018) Post-Campylobacter Guillain Barr\u00e9 Syndrome in the USA. Secondary analysis of surveillance data collected during the 2009\u20132010 novel Influenza A (H1N1) vaccination campaign. Epidemiol Infect 146(13):1740\u20131745. \n                    https:\/\/doi.org\/10.1017\/S0950268818001802","journal-title":"Epidemiol Infect"},{"key":"2913_CR19","first-page":"26","volume":"3","author":"K Wei\u00dfer","year":"2017","unstructured":"Wei\u00dfer K, Matheis W, Keller-Stanislawski B (2017) Entwicklung eines PBTK-Modells f\u00fcr die Risikobewertung der Aluminiumexposition aus Adjuvanzien. Bull Arzneimittelsicherh 3:26\u201329","journal-title":"Bull Arzneimittelsicherh"},{"key":"2913_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/2329048X15620641","author":"M Matsui","year":"2016","unstructured":"Matsui M, Shimizu M, Ioi A et al (2016) Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and Guillain-Barre syndrome in a\u00a016-month-old child. Child Neurol Open. \n                    https:\/\/doi.org\/10.1177\/2329048X15620641","journal-title":"Child Neurol Open"},{"issue":"1","key":"2913_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejpn.2015.11.004","volume":"20","author":"C Spagnoli","year":"2016","unstructured":"Spagnoli C, Iodice A, Salerno GG et al (2016) CMV-associated axonal sensory-motor Guillain-Barr\u00e9 syndrome in a\u00a0child. Case report and review of the literature. Eur J Paediatr Neurol 20(1):168\u2013175. \n                    https:\/\/doi.org\/10.1016\/j.ejpn.2015.11.004","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"2913_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10096-018-3199-5","volume":"37","author":"B Islam","year":"2018","unstructured":"Islam B, Islam Z, GeurtsvanKessel CH et al (2018) Guillain-Barr\u00e9 syndrome following varicella-zoster virus infection. Eur J Clin Microbiol Infect Dis 37(3):511\u2013518. \n                    https:\/\/doi.org\/10.1007\/s10096-018-3199-5","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10027","key":"2913_CR23","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau VM, Blake A, Mons S et al (2016) Guillain-Barr\u00e9 Syndrome outbreak associated with Zika virus infection in French Polynesia. A case-control study. Lancet 387(10027):1531\u20131539. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)00562-6","journal-title":"Lancet"},{"issue":"2","key":"2913_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","volume":"110","author":"LB Schonberger","year":"1979","unstructured":"Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ et al (1979) Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977. Am J Epidemiol 110(2):105\u2013123","journal-title":"Am J Epidemiol"},{"issue":"8","key":"2913_CR25","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/cid\/ciu005","volume":"58","author":"C Vellozzi","year":"2014","unstructured":"Vellozzi C, Iqbal S, Broder K (2014) Guillain-Barre syndrome, influenza, and influenza vaccination. The epidemiologic evidence. Clin Infect Dis 58(8):1149\u20131155. \n                    https:\/\/doi.org\/10.1093\/cid\/ciu005","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2913_CR26","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s00431-014-2318-2","volume":"173","author":"E Bergfors","year":"2014","unstructured":"Bergfors E, Hermansson G, Nystr\u00f6m Kronander U, Falk L, Valter L, Trollfors B (2014) How common are long-lasting, intensely itching vaccination granulomas and contact allergy to aluminium induced by currently used pediatric vaccines? A prospective cohort study. Eur J Pediatr 173(10):1297\u20131307. \n                    https:\/\/doi.org\/10.1007\/s00431-014-2318-2","journal-title":"Eur J Pediatr"},{"issue":"9","key":"2913_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0248-8663(99)80039-3","volume":"19","author":"RK Gherardi","year":"1998","unstructured":"Gherardi RK, Ch\u00e9rin P (1998) La myofasciite \u00e0 macrophages. Une nouvelle entit\u00e9. Groupe d\u2019\u00e9tudes et recherche sur les maladies musculaires acquises et dysimmunitaires (GERMMAD) de l\u2019association fran\u00e7aise contre les myopathies (AFM) (Macrophagic fasciitis: a\u00a0new entity. Groupe d\u2019\u00e9tudes et recherche surles maladies musculaires acquises et disimmunitaires (GERMMAD) de l\u2019association fran\u00e7aise contre les myopathies (AFM)). Rev Med Interne 19(9):617\u2013618","journal-title":"Rev Med Interne"},{"issue":"Pt 9","key":"2913_CR28","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/brain\/124.9.1821","volume":"124","author":"RK Gherardi","year":"2001","unstructured":"Gherardi RK, Coquet M, Cherin P et al (2001) Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 124(Pt 9):1821\u20131831","journal-title":"Brain"},{"issue":"11","key":"2913_CR29","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.vaccine.2004.09.012","volume":"23","author":"F Verdier","year":"2005","unstructured":"Verdier F, Burnett R, Michelet-Habchi C, Moretto P, Fievet-Groyne F, Sauzeat E (2005) Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey. Vaccine 23(11):1359\u20131367. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2004.09.012","journal-title":"Vaccine"},{"key":"2913_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12887-015-0318-7","volume":"15","author":"J M\u00fcller-Nordhorn","year":"2015","unstructured":"M\u00fcller-Nordhorn J, Hettler-Chen C\u2011M, Keil T, Muckelbauer R (2015) Association between sudden infant death syndrome and diphtheria-tetanus-pertussis immunisation. An ecological study. BMC Pediatr 15:1. \n                    https:\/\/doi.org\/10.1186\/s12887-015-0318-7","journal-title":"BMC Pediatr."},{"key":"2913_CR31","volume-title":"TOKEN-Studie \u00fcber Todesf\u00e4lle bei Kindern im 2. bis 24. Lebensmonat","author":"Robert Koch-Institut","year":"2014","unstructured":"Robert Koch-Institut (2014) TOKEN-Studie \u00fcber Todesf\u00e4lle bei Kindern im 2. bis 24. Lebensmonat. \n                    https:\/\/www.rki.de\/DE\/Content\/Gesundheitsmonitoring\/Studien\/Weitere_Studien\/TOKEN_Studie\/token_node.html\n                    \n                  ; Zugegriffen: 26.02.2019"},{"issue":"2","key":"2913_CR32","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.vaccine.2006.07.027","volume":"25","author":"MMT Vennemann","year":"2007","unstructured":"Vennemann MMT, Butterfass-Bahloul T, Jorch G et al (2007) Sudden infant death syndrome. No increased risk after immunisation. Vaccine 25(2):336\u2013340. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2006.07.027","journal-title":"Vaccine"},{"key":"2913_CR33","volume-title":"Todesursachenstatistik ab 1998. Sterbef\u00e4lle, Sterbeziffern (je 100.000 Einwohner, altersstandardisiert)","author":"Statistisches Bundesamt","year":"2014","unstructured":"Statistisches Bundesamt (2014) Todesursachenstatistik ab 1998. Sterbef\u00e4lle, Sterbeziffern (je 100.000 Einwohner, altersstandardisiert) (\n                    www.gbe-bund.de\n                    \n                  )"},{"issue":"9","key":"2913_CR34","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1001\/jama.2018.0708","volume":"319","author":"JM Glanz","year":"2018","unstructured":"Glanz JM, Newcomer SR, Daley MF et al (2018) Association between estimated cumulative vaccine antigen exposure through the first 23 months of life and non-vaccine-targeted infections from 24 through 47 months of age. JAMA 319(9):906\u2013913. \n                    https:\/\/doi.org\/10.1001\/jama.2018.0708","journal-title":"JAMA"},{"issue":"6235","key":"2913_CR35","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1126\/science.aaa3662","volume":"348","author":"MJ Mina","year":"2015","unstructured":"Mina MJ, Metcalf CJE, de Swart RL, Osterhaus ADME, Grenfell BT (2015) Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science 348(6235):694\u2013699. \n                    https:\/\/doi.org\/10.1126\/science.aaa3662","journal-title":"Science"},{"issue":"2","key":"2913_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/path.4457","volume":"235","author":"M Ludlow","year":"2015","unstructured":"Ludlow M, McQuaid S, Milner D, de Swart RL, Duprex WP (2015) Pathological consequences of systemic measles virus infection. J\u00a0Pathol 235(2):253\u2013265. \n                    https:\/\/doi.org\/10.1002\/path.4457","journal-title":"J Pathol"},{"issue":"12","key":"2913_CR37","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/pds.3482","volume":"22","author":"S Iqbal","year":"2013","unstructured":"Iqbal S, Barile JP, Thompson WW, DeStefano F (2013) Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7\u201310 years. Pharmacoepidemiol Drug Saf 22(12):1263\u20131270. \n                    https:\/\/doi.org\/10.1002\/pds.3482","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9103","key":"2913_CR38","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0140-6736(97)11096-0","volume":"351","author":"AJ Wakefield","year":"1998","unstructured":"Wakefield AJ, Murch SH, Anthony A et al (1998) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351(9103):637\u2013641","journal-title":"Lancet"},{"key":"2913_CR39","doi-asserted-by":"publisher","first-page":"c696","DOI":"10.1136\/bmj.c696","volume":"340","author":"C Dyer","year":"2010","unstructured":"Dyer C (2010) Lancet retracts Wakefield\u2019s MMR paper. BMJ 340:c696. \n                    https:\/\/doi.org\/10.1136\/bmj.c696","journal-title":"BMJ"},{"key":"2913_CR40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1024\/1422-4917\/a000288","volume":"42","author":"C Freitag","year":"2014","unstructured":"Freitag C (2014) Autismus-Spektrum St\u00f6rung nach DSM-5. Z\u00a0Kinder Jugendpsychiatr Psychother 42:185\u2013192. \n                    https:\/\/doi.org\/10.1024\/1422-4917\/a000288","journal-title":"Z Kinder Jugendpsychiatr Psychother"},{"issue":"2","key":"2913_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1542\/peds.113.2.259","volume":"113","author":"F DeStefano","year":"2004","unstructured":"DeStefano F, Bhasin TK, Thompson WW, Yeargin-Allsopp M, Boyle C (2004) Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a\u00a0population-based study in metropolitan atlanta. Pediatrics 113(2):259\u2013266","journal-title":"Pediatrics"},{"issue":"5","key":"2913_CR42","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/INF.0b013e3181c40a8a","volume":"29","author":"D Mrozek-Budzyn","year":"2010","unstructured":"Mrozek-Budzyn D, Kieltyka A, Majewska R (2010) Lack of association between measles-mumps-rubella vaccination and autism in children: a\u00a0case-control study. Pediatr Infect Dis\u00a0J 29(5):397\u2013400. \n                    https:\/\/doi.org\/10.1097\/INF.0b013e3181c40a8a","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"2913_CR43","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1542\/peds.2010-0309","volume":"126","author":"CS Price","year":"2010","unstructured":"Price CS, Thompson WW, Goodson B et\u00a0al (2010) Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics 126(4):656\u2013664. \n                    https:\/\/doi.org\/10.1542\/peds.2010-0309","journal-title":"Pediatrics"},{"issue":"9438","key":"2913_CR44","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S0140-6736(04)17020-7","volume":"364","author":"L Smeeth","year":"2004","unstructured":"Smeeth L, Cook C, Fombonne E et al (2004) MMR vaccination and pervasive developmental disorders: a\u00a0case-control study. Lancet 364(9438):963\u2013969. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(04)17020-7","journal-title":"Lancet"},{"issue":"28","key":"2913_CR45","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1016\/j.vaccine.2012.01.093","volume":"30","author":"Y Uno","year":"2012","unstructured":"Uno Y, Uchiyama T, Kurosawa M, Aleksic B, Ozaki N (2012) The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia. Vaccine 30(28):4292\u20134298. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2012.01.093","journal-title":"Vaccine"},{"issue":"21","key":"2913_CR46","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.vaccine.2014.12.036","volume":"33","author":"Y Uno","year":"2015","unstructured":"Uno Y, Uchiyama T, Kurosawa M, Aleksic B, Ozaki N (2015) Early exposure to the combined measles-mumps-rubella vaccine and thimerosal-containing vaccines and risk of autism spectrum disorder. Vaccine 33(21):2511\u20132516. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2014.12.036","journal-title":"Vaccine"},{"key":"2913_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004407.pub3","author":"V Demicheli","year":"2012","unstructured":"Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C (2012) Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD004407.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"29","key":"2913_CR48","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1016\/j.vaccine.2014.04.085","volume":"32","author":"LE Taylor","year":"2014","unstructured":"Taylor LE, Swerdfeger AL, Eslick GD (2014) Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine 32(29):3623\u20133629. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.085","journal-title":"Vaccine"},{"issue":"5","key":"2913_CR49","doi-asserted-by":"publisher","first-page":"332","DOI":"10.4161\/hv.5.5.7211","volume":"5","author":"D Descamps","year":"2009","unstructured":"Descamps D, Hardt K, Spiessens B et al (2009) Safety of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine for cervical cancer prevention. A pooled analysis of 11 clinical trials. Hum Vaccin 5(5):332\u2013340","journal-title":"Hum Vaccin"},{"key":"2913_CR50","doi-asserted-by":"publisher","first-page":"f5906","DOI":"10.1136\/bmj.f5906","volume":"347","author":"L Arnheim-Dahlstr\u00f6m","year":"2013","unstructured":"Arnheim-Dahlstr\u00f6m L, Pasternak B, Svanstr\u00f6m H, Spar\u00e9n P, Hviid A (2013) Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden. Cohort study. BMJ 347:f5906","journal-title":"BMJ"},{"issue":"4","key":"2913_CR51","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/joim.12155","volume":"275","author":"L Grimaldi-Bensouda","year":"2014","unstructured":"Grimaldi-Bensouda L, Guillemot D, Godeau B et al (2014) Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects. J\u00a0Intern Med 275(4):398\u2013408. \n                    https:\/\/doi.org\/10.1111\/joim.12155","journal-title":"J Intern Med"},{"issue":"2","key":"2913_CR52","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/joim.12694","volume":"283","author":"A Hviid","year":"2018","unstructured":"Hviid A, Svanstr\u00f6m H, Scheller NM, Gr\u00f6nlund O, Pasternak B, Arnheim-Dahlstr\u00f6m L (2018) Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases. J\u00a0Intern Med 283(2):154\u2013165. \n                    https:\/\/doi.org\/10.1111\/joim.12694","journal-title":"J Intern Med"},{"issue":"Suppl 1","key":"2913_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10937400701597766","volume":"10","author":"D Krewski","year":"2007","unstructured":"Krewski D, Yokel RA, Nieboer E et\u00a0al (2007) Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J\u00a0Toxicol Environ Health B Crit Rev 10(Suppl 1):1\u2013269. \n                    https:\/\/doi.org\/10.1080\/10937400701597766","journal-title":"J Toxicol Environ Health B Crit Rev"},{"issue":"5","key":"2913_CR54","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1039\/B314329P","volume":"6","author":"ND Priest","year":"2004","unstructured":"Priest ND (2004) The biological behaviour and bioavailability of aluminium in man, with special reference to studies employing aluminium-26 as a\u00a0tracer. Review and study update. J\u00a0Environ Monit 6(5):375\u2013403. \n                    https:\/\/doi.org\/10.1039\/b314329p","journal-title":"J Environ Monit"},{"issue":"2","key":"2913_CR55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/0148607192016002157","volume":"16","author":"D Bougle","year":"1992","unstructured":"Bougle D, Bureau F, Voirin J, Neuville D, Duhamel JF (1992) A cross-sectional study of plasma and urinary aluminum levels in term and preterm infants. JPEN J Parenter Enteral Nutr 16(2):157\u2013159. \n                    https:\/\/doi.org\/10.1177\/0148607192016002157","journal-title":"JPEN J. Parenter. Enteral Nutr."},{"issue":"4","key":"2913_CR56","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/00005176-199411000-00002","volume":"19","author":"NM Hawkins","year":"1994","unstructured":"Hawkins NM, Coffey S, Lawson MS, Delves HT (1994) Potential aluminium toxicity in infants fed special infant formula. J\u00a0Pediatr Gastroenterol Nutr 19(4):377\u2013381","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2913_CR57","volume-title":"Impfkalender","author":"STIKO","year":"2018","unstructured":"STIKO (2018) Impfkalender. \n                    https:\/\/www.rki.de\/DE\/Content\/Kommissionen\/STIKO\/Empfehlungen\/Aktuelles\/Impfkalender.html\n                    \n                   Zugegriffen: 26.02.2019"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-019-02913-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-019-02913-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-019-02913-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:13:09Z","timestamp":1582848789000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-019-02913-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["2913"],"URL":"https:\/\/doi.org\/10.1007\/s00103-019-02913-1","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]},"assertion":[{"value":"28 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.\u00a0Oberle, D.\u00a0Mentzer, F.\u00a0Rocha, R.\u00a0Streit, K.\u00a0Wei\u00dfer und B.\u00a0Keller-Stanislawski geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}